New Hemorrhagic Cystitis Clinical Trial
- David
- Nov 8, 2020
- 1 min read
Updated: Nov 9, 2020
A clinical trial for hemorrhagic cystitis testing a new experimental drug, LP-10 (intravesical tacrolimus) is open for enrollment for qualifying patients at sites in the Pittsburgh, PA and Detroit, MI areas. The trial sponsor is Lipella Pharmaceuticals.
The title of the trial is: A Multicenter, Dose-Ranging, Placebo-Controlled Trial Evaluating the Safety, Tolerability and Efficacy of LP-10 in Subjects With Refractory Moderate to Severe Hemorrhagic Cystitis.
To learn more, including inclusion/exclusion criteria and contact information, see the ClinicalTrials.gov entry in the link (https://clinicaltrials.gov/ct2/show/NCT03129126). ClinicalTrials.gov Identifier: NCT03129126.
Disclaimer: This post is not a recommendation to join the trial and was made for awareness only. Please weigh all trial details and consult with a healthcare professional before enrolling in any potential clinical trial.
Supplement by Ron. Avoid even the beginning of constipation by 1. Taking Miralax daily and 2. Drinking more water than the recommended 64 ounces a day. Both are crucial steps in preventing bloody urine. If bloody urine occurs, immediately drink a large amount of water (30+ ounces) to prevent new clots and flush out any small ones. It takes about 5 minutes for the water you drink to get into the bladder. Try early urination. Success is when urine becomes clear.